These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The Future of Nonalcoholic Fatty Liver Disease Treatment. Mazhar K Med Clin North Am; 2019 Jan; 103(1):57-69. PubMed ID: 30466676 [TBL] [Abstract][Full Text] [Related]
6. Nonalcoholic fatty liver disease, association with cardiovascular disease and treatment (II). The treatment of nonalcoholic fatty liver disease. Brea Á; Pintó X; Ascaso JF; Blasco M; Díaz Á; González-Santos P; Hernández-Mijares A; Mantilla T; Millán J; Pedro-Botet J; Clin Investig Arterioscler; 2017; 29(4):185-200. PubMed ID: 27692632 [TBL] [Abstract][Full Text] [Related]
7. Nonalcoholic Fatty Liver Disease: Pathophysiology and Management. Carr RM; Oranu A; Khungar V Gastroenterol Clin North Am; 2016 Dec; 45(4):639-652. PubMed ID: 27837778 [TBL] [Abstract][Full Text] [Related]
8. Similarities and differences between pediatric and adult nonalcoholic fatty liver disease. Crespo M; Lappe S; Feldstein AE; Alkhouri N Metabolism; 2016 Aug; 65(8):1161-71. PubMed ID: 26961580 [TBL] [Abstract][Full Text] [Related]
9. Nonalcoholic fatty liver disease - current status and future directions. Demir M; Lang S; Steffen HM J Dig Dis; 2015 Oct; 16(10):541-57. PubMed ID: 26406351 [TBL] [Abstract][Full Text] [Related]
10. Serum cytokeratin-18 and its relation to liver fibrosis and steatosis diagnosed by FibroScan and controlled attenuation parameter in nonalcoholic fatty liver disease and hepatitis C virus patients. Darweesh SK; AbdElAziz RA; Abd-ElFatah DS; AbdElazim NA; Fathi SA; Attia D; AbdAllah M Eur J Gastroenterol Hepatol; 2019 May; 31(5):633-641. PubMed ID: 30839434 [TBL] [Abstract][Full Text] [Related]
11. Noninvasive evaluation of nonalcoholic fatty liver disease: Current evidence and practice. Zhou JH; Cai JJ; She ZG; Li HL World J Gastroenterol; 2019 Mar; 25(11):1307-1326. PubMed ID: 30918425 [TBL] [Abstract][Full Text] [Related]
18. Clinical epidemiology and disease burden of nonalcoholic fatty liver disease. Perumpail BJ; Khan MA; Yoo ER; Cholankeril G; Kim D; Ahmed A World J Gastroenterol; 2017 Dec; 23(47):8263-8276. PubMed ID: 29307986 [TBL] [Abstract][Full Text] [Related]
19. Recommendations for Diagnosis, Referral for Liver Biopsy, and Treatment of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis. Spengler EK; Loomba R Mayo Clin Proc; 2015 Sep; 90(9):1233-46. PubMed ID: 26219858 [TBL] [Abstract][Full Text] [Related]
20. Nonalcoholic Fatty Liver Disease: Identification and Management of High-Risk Patients. Cheung A; Figueredo C; Rinella ME Am J Gastroenterol; 2019 Apr; 114(4):579-590. PubMed ID: 30839326 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]